SX29
SX29 is an orally active, non-competitive α-glucosidase inhibitor (IC50 = 2.12 μM) with demonstrated hypoglycemic effects. In vivo studies show it improves glucose tolerance and lowers blood glucose in diabetic mouse models, supporting its research use in diabetes and metabolic disorder investigations.
Product Specifications
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog